Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
株式のランク #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
株価
$0.00695
最終同期: 2024-10-29
時価総額
$536.40
変化(1日)
-0.71%
変化(1年)
0.00%
US
取引 BIOLASE, Inc. (BIOL)

カテゴリー

BIOLASE, Inc.(BIOL)のP/E比率
August 2026 時点のP/E比率 TTM 0.00
BIOLASE, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 0.00 です。2022 年末時点での P/E は -0.16 でした。
BIOLASE, Inc. の P/E 比率の履歴(2000 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 0.00 -98.29%
2023 -0.07 -55.88%
2022 -0.16 -95.59%
2021 -3.57 133.74%
2020 -1.53 113.47%
2019 -0.71 -24.55%
2018 -0.95 -49.66%
2017 -1.88 -65.94%
2016 -5.53 129.22%
2015 -2.41 -61.44%
2014 -6.25 -26.96%
2013 -8.56 -57.80%
2012 -20.28 13.38%
2011 -17.89 365.23%
2010 -3.85 -77.06%
2009 -16.76 297.64%
2008 -4.22 -48.97%
2007 -8.26 -82.35%
2006 -46.80 316.41%
2005 -11.24 -3.09%
2004 -11.60 -159.36%
2003 19.54 -56.04%
2002 44.44 -115.29%
2001 -290.61 3,034.63%
2000 -9.27 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
33.99 -2,832,358.33%
US
33.47 -2,789,583.33%
US
21.39 -1,782,416.67%
IE
18.84 -1,570,325.00%
US
49.47 -4,122,225.00%
US
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。